Results 121 to 130 of about 2,137,881 (310)

Some Inequalities About the Kaplan-Meier Estimator

open access: yesThe Annals of Statistics, 1992
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
openaire   +2 more sources

Comprehensive Characterization of 98 Chinese Cases of Genetic Creutzfeldt‐Jakob Disease With T188K Mutation

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterize the demographic, clinical, and laboratory features of the Chinese patients of genetic Creutzfeldt‐Jakob disease with T188K variant (T188K‐gCJD), the most common subtype of genetic prion diseases (gPrDs) in China. Methods In this nationwide retrospective study, data from 98 genetically confirmed T188K‐gCJD patients ...
Chun‐Jie Li   +11 more
wiley   +1 more source

A Note on the Uniform Consistency of the Kaplan-Meier Estimator

open access: yesThe Annals of Statistics, 1987
Let \(\{X_ n\), \(n\geq 1\}\) be i.i.d. with \(P(X_ i\leq u)=F(u)\) and \(\{U_ n\), \(n\geq 1\}\) be i.i.d. with \(P(U_ i\leq u)=G(u)\). \(\hat F_ n(t)\) is the Kaplan-Meier estimator based on the censored data \((\tilde X_ i=X_ i\wedge U_ i\), \(\delta_ i=1_{(X_ i\leq U_ i)}\), \(1\leq i\leq n)\).
openaire   +2 more sources

Kaplan-Meier estimate of time to first treatment switch.

open access: yes, 2014
Kaplan-Meier estimate of time to first treatment switch.
Katherine Nedrow (449577)   +7 more
core   +1 more source

Uncovering G Protein‐Coupled Receptors: Novel Targets and Biomarkers for Predicting Glioma Prognosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Low‐grade gliomas (LGG) exhibit significant heterogeneity and recurrence risk. G protein‐coupled receptors (GPCR) contribute to glioma malignant progression, but their prognostic value remains unclear. This work attempts to formulate a GPCR‐based outcome‐predicting model for LGG. Methods Based on TCGA LGG data, the enrichment scores
Jun Yang   +4 more
wiley   +1 more source

Kaplan-Meier analysis (product-limit estimate of time to event).

open access: yes, 2013
Kaplan-Meier analysis (product-limit estimate of time to event).
Jorge Alvar (253327)   +8 more
core   +1 more source

Subclinical Optic Nerve Involvement in Radiologically Isolated Syndrome: Multimodal Detection and Diagnostic Impact

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives We aimed to determine the frequency of subclinical optic nerve (ON) lesions using MRI, optical coherence tomography (OCT), and visual evoked potentials (VEP) in radiologically isolated syndrome (RIS), and to assess their diagnostic and prognostic significance.
Christine Lebrun‐Frenay   +13 more
wiley   +1 more source

Kaplan-Meier survival estimate of the main effectiveness analysis.

open access: yes, 2015
Kaplan-Meier survival estimate of the main effectiveness analysis.
Fabiana Alves (217602)   +15 more
core   +1 more source

Electroencephalographic Normalization as a Biomarker of Clinical Recovery in Down Syndrome Regression Disorder

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Down syndrome regression disorder is a syndrome characterized by subacute loss of cognitive, behavioral, and functional abilities in individuals with Down syndrome. Electroencephalography abnormalities are frequently observed during evaluation, but it remains unclear whether these findings represent a dynamic marker of disease ...
Jonathan D. Santoro   +14 more
wiley   +1 more source

The Kaplan Meier Estimate in Survival Analysis [PDF]

open access: yesBiometrics & Biostatistics International Journal, 2017
Kaplan-Meier is a statistical method used in the analysis of time to event data. Time to event means the time from entry into a study until a particular event, for example onset of illness. This method is very useful in survival analysis as it is used by the researchers to determine and/or analyze the patients or participants who lost to follow up or ...
openaire   +1 more source

Home - About - Disclaimer - Privacy